Talcum Powder / Ovarian Cancer

● CAMPAIGN OPEN POST-BANKRUPTCY / REORGANIZATION 10 signals
Ovarian Cancer / Mesothelioma  ·  Baby Powder / Shower-to-Shower
DEFENDANT
Johnson & Johnson
MDL / DOCKET
MDL 2738
D. New Jersey
JUDGE
Hon. Michael Shipp
PLAINTIFFS
62,000+
BELLWETHER / TRIAL
TBD post-reorganization
SETTLEMENT STATUS
$8.9B Proposed (J&J bankruptcy)
📋 Case Overview

Johnson & Johnson’s talcum powder products (Baby Powder, Shower-to-Shower) are alleged to contain asbestos and cause ovarian cancer and mesothelioma. J&J created subsidiary LTL Management and filed for bankruptcy twice to limit liability. Both attempts were rejected by appellate courts. A third bankruptcy attempt and $8.9B settlement plan are currently before the court.

⚗ CAUSATION SUMMARY

Ovarian cancer (perineal talc application) and mesothelioma (asbestos-contaminated talc) are the two injury tracks. Causation for ovarian cancer is contested — several meta-analyses show elevated risk; industry disputes methodology. Mesothelioma cases are stronger on causation given clear asbestos-cancer link.

⚖️ Litigation Status HOLDING — BANKRUPTCY UNCERTAINTY
MDL / Court
MDL 2738 — Active (D.N.J.) + Bankruptcy proceedings
Active Plaintiffs
62,000+

J&J’s third bankruptcy attempt and $8.9B settlement plan are before the court. The 3rd Circuit rejected two prior attempts. Ovarian cancer and mesothelioma cases remain on hold pending bankruptcy resolution. State court trials have produced major plaintiff verdicts.

Key Verdicts & Settlements
⚖️
Missouri jury — $4.69B verdict (2018)
22 plaintiffs. Largest single verdict in talc litigation. Reduced but affirmed on appeal.
⚖️
New Jersey $750M verdict (2023)
Mesothelioma case. Significant pre-bankruptcy state court win.
🏛️
3rd Circuit rejects LTL bankruptcy — twice (2022, 2023)
Courts held J&J not in financial distress required for Chapter 11. Third attempt pending.
💰
$8.9B settlement plan filed (2024)
Requires 75% plaintiff vote for approval. Outcome determines resolution timeline.
⏸️
Filing trend: Paused/Uncertain. Bankruptcy proceedings have frozen active litigation. Resolution depends on court approval of $8.9B plan. If rejected, full MDL litigation resumes.
📍 Geographic Exposure
Nationwide
Highest plaintiff concentration: Southeast, Northeast, Midwest
No geographic restriction — product sold nationally for decades
🏢 Key Defendants
DEFENDANT
ROLE
INTEL NOTE
Johnson & Johnson
Manufacturer and marketer
Third bankruptcy attempt pending; $8.9B settlement proposed
LTL Management LLC
J&J spinoff bankruptcy entity
Created to isolate talc liability; courts rejected first two attempts
Imerys Talc
Talc supplier (bankrupt)
Filed Chapter 11 2019; separate claim process
✅ Campaign Eligibility Criteria
Regular perineal application of J&J talcum powder for 1+ years
Diagnosed with epithelial ovarian cancer OR mesothelioma
Diagnosis after 1990 (primary exposure window)
Female (ovarian cancer track) or any gender (mesothelioma track)
These criteria reflect general case strength indicators and are not legal advice. Contact CloudIntake to screen individual claimants.
📅 Litigation Timeline
1971
First published study links perineal talc use to ovarian cancer
2016
First major jury verdicts: $72M and $55M for plaintiffs
2019
J&J recalls talcum powder after FDA finds asbestos traces
2021
J&J creates LTL Management; files Chapter 11 bankruptcy (rejected by 3rd Cir.)
2023
Second bankruptcy attempt dismissed by 3rd Circuit
2024
Third bankruptcy + $8.9B settlement plan filed; pending court approval
Talcum Powder / Ovarian Cancer — Intelligence Feed ⚖ 51 filings/30d ↑ LIVE
📰 NEWS
Johnson & Johnson talc class action lawsuit ends in $250K Philadelphia verdict
Mar 13, 2026 Class Action Lawsuits Read Source →
📰 NEWS
What Another Verdict Against J&J Means for the Talcum Powder Lawsuits
Mar 13, 2026 Consumer Notice Read Source →
📰 NEWS
Critical Mass With Law.com’s Amanda Bronstad: Two Talc Trials Take Off Against Johnson & Johnson, Abbott Faces Another Trial Over Preterm In…
fant Formula
Mar 13, 2026 Law.com Read Source →
📰 NEWS
Pennsylvania jury finds Johnson & Johnson liable for cancer in latest talc trial
Mar 13, 2026 Reuters Read Source →
📰 NEWS
Baltimore jury orders J&J to pay $1.5B in largest-ever award to a talc plaintiff
Mar 13, 2026 Fierce Pharma Read Source →
📰 NEWS
$20M Verdict Hits J&J in Talc Trial Over Florida Doctor's Death
Mar 13, 2026 CVN News Read Source →
📰 NEWS
Talc and Cancer: What Johnson & Johnson’s $40 Million Verdict Means for Public Health
Mar 13, 2026 Oncodaily Read Source →
📰 NEWS
Massive J&J verdicts set stage for 2026 talc litigants
Mar 13, 2026 Massachusetts Lawyers Weekly Read Source →
📡 SIGNAL
Ward v. Johnson & Johnson — District Court, M.D. Florida
Mar 29, 2026 CourtListener / PACER Read Source →
📡 SIGNAL
Ward v. Johnson & Johnson — District Court, M.D. Florida
Mar 22, 2026 CourtListener / PACER Read Source →
Feed All Torts
MASS TORT AD AGENCY
Saturated market. Unsaturated audiences.
Every firm is fishing the same pond for Talcum Powder / Ovarian Cancer leads. MTAA targets underserved audiences and demographics your competitors ignore.
See the Strategy →
Plaintiff attorneys only · mtaa.ai
JACOB SCORE™
Talcum Powder / Ovarian Cancer
70 / 100
ScienceModerate
MomentumModerate
CampaignModerate
TimelineModerate
VerdictsStrong
MAJOR VERDICTS · BANKRUPTCY RISK
Jacob Score™ — Methodology & Legal Disclaimers
The Jacob Score is a composite 1–100 litigation opportunity index for mass torts, produced by the TortIntel editorial team at Mass Tort Ad Agency. It is updated periodically as litigation conditions change.

Score Dimensions (each rated 1–5)

Science — Peer-reviewed study quality and quantity, relative risk magnitude, replication across independent research groups, FDA or regulatory action taken, and estimated Daubert survivability based on published expert testimony and prior rulings.

Momentum — MDL formation and phase, plaintiff count trajectory, case consolidation activity, and overall litigation velocity.

Campaign — Current filing window status, case saturation, defendant solvency, estimated qualifying population size, and co-defendant dynamics.

Timeline — Proximity to first expected resolution or bellwether trial, current discovery or Daubert phase, and estimated time-to-value for a signed plaintiff.

Verdicts — Confirmed plaintiff jury verdicts, bellwether trial win/loss record, and size or certainty of any established settlement fund. 1 = pre-trial · 2 = mixed early results · 3 = partial settlements or initial wins · 4 = confirmed large verdicts or funded settlement · 5 = landmark verdicts with formal settlement program.

LEGAL DISCLAIMERS

The Jacob Score and all associated content on TortIntel.ai is provided solely for mass tort business intelligence and law firm marketing decision-making purposes. It does not constitute legal advice, litigation strategy advice, or a recommendation to file or refrain from filing any lawsuit.

The Jacob Score is an editorial opinion based on publicly available data including court filings, published scientific literature, regulatory actions, and reported settlement information. It is not a guarantee of future litigation outcomes. Past verdicts and settlements are not predictive of future results in any specific case.

TortIntel.ai and Mass Tort Ad Agency make no representation that any score is complete, accurate, or current. Litigation conditions change rapidly. Attorneys must conduct independent due diligence and consult qualified co-counsel before making any case acquisition or litigation funding decisions based on this or any other intelligence tool.

This score must not be used to evaluate, accept, or reject any individual plaintiff’s case. Case-specific merit depends on individual facts, applicable state law, expert medical and scientific analysis, and jurisdiction-specific statutes of limitations — all of which are beyond the scope of this tool.

No attorney-client relationship is created by use of this platform. TortIntel.ai is not a law firm and does not provide legal services. © 2026 Mass Tort Ad Agency / TortIntel.ai. All rights reserved.
DATA ACCURACY
See something incorrect? Reach out and we'll fix it.
🔔 Alert Me
Get notified when Talcum Powder / Ovarian Cancer updates.
✓ You're subscribed. We'll notify you of key developments.
TORTINTEL PRO
Abuse Discovery Tracker
Emerging institutional abuse cases — church, scouting, youth programs. Real-time defendant monitoring, filing window alerts, and filing cluster detection.
View Pro Features →